臨床検査サービスの世界市場：市場規模・シェア・動向分析 (検査の種類別・サービスプロバイダー別・用途別・地域別)、セグメント別予測 (2025年～2030年)

臨床検査サービス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の臨床検査サービスの市場規模は2030年までに2,867億7,000万米ドルに達し、2025年から2030年までのCAGRは3.82％を記録すると予測されています。

この業界の成長は、高齢者人口の増加によるものであり、その結果、疾病の早期診断に対する需要が高まっています。糖尿病や心血管疾患（CVD）などの対象疾患の有病率の増加は、予測期間中の業界成長にとってインパクトの大きい促進要因です。心血管疾患は世界の死因のトップです。疾病管理に関するアンメット・メディカル・ニーズの存在と、それに続くより多くの地域での患者意識の高まりが、臨床検査室検査の需要を押し上げると予想されます。

画期的な進歩や漸進的な進歩による臨床検査技術の向上は、業界成長のインパクトの大きい促進要因です。市場企業は、患者のアンメットニーズに応えるため、新しいサービスの導入に取り組んでいます。例えば、2022年5月、ハミルトン郡はEthos Laboratoriesと提携し、COVID-19検査施設を無料で開設しました。2022年7月には、メイヨークリニックの検査室がサル痘検査を開始し、より多くの対象者が利用できるようになりました。さらに、2022年1月、Quest Diagnostics社は、eMed社との提携により、QuestDirectを通じて利用可能なCOVID-19迅速抗原検査を開始し、自宅でのCOVID-19検査へのアクセスを提供します。パンデミックは全世界で数百万人に影響を与えました。CDCとWHOによると、COVID-19の診断の標準は呼吸器からのサンプルのRT-PCRです。

COVID-19の診断にPCR技術を採用し、治療法開発のためにウイルスの遺伝子配列を決定することが、業界を牽引しています。このパンデミックのため、新型コロナウイルスの診断のための検査の承認が増加しており、これらの検査のほとんどは連邦政府機関による緊急使用認可（EUA）の下で承認されています。さらに、この業界は検査室や病院といった異なる販売チャネルを通じて事業を展開しています。様々な地域に有力なプレーヤーが存在することが、業界を牽引すると予想されます。例えば、2022年2月、LabcorpはAscensionと包括的パートナーシップを締結しました。この提携により、Labcorpは10州にあるAscensionの病院内検査室を扱い、アウトリーチ検査室事業のための資産を購入します。

臨床検査サービス市場：分析概要

• 検査の種類別では、臨床化学分野が2024年に56.60%の最大売上シェアで市場をリード。
• サービスプロバイダー別では、病院ベース検査室セグメントが2024年に最大の市場シェアを占めました。
• 用途別では、バイオ分析・ラボ化学サービス分野が2024年に最大の収益シェアを占めました。
• 臨床検査サービス市場は北米が2024年に37.24％の最大収益シェアを占めました。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 臨床検査サービス市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 臨床検査サービス市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析
• 価格分析

第4章 臨床検査サービス市場：検査の種類別の推定・動向分析

• 市場シェア：検査の種類別（2023年・2030年）
• セグメント別ダッシュボード
• 世界の臨床検査サービス市場の展望：検査の種類別
• 市場規模の予測と動向分析（2018～2030年）
  • 遺伝子検査
  • 臨床化学
  • 医療微生物検査
  • 血液検査
  • 免疫学的検査
  • 細胞診検査
  • 薬物乱用検査
  • その他の難解なテスト

第5章 臨床検査サービス市場：サービスプロバイダー別の推定・動向分析

• 市場シェア：サービスプロバイダー別（2023年・2030年）
• セグメント別ダッシュボード
• 世界の臨床検査サービス市場の展望：サービスプロバイダー別
• 市場規模の予測と動向分析（2018～2030年）
  • 病院併設検査室
  • 独立型検査室
  • クリニックベース検査室

第6章 臨床検査サービス市場：用途別の推定・動向分析

• 市場シェア：用途別（2023年・2030年）
• セグメント別ダッシュボード
• 世界の臨床検査サービス市場の展望：用途別
• 市場規模の予測と動向分析（2018～2030年）
  • バイオ分析・ラボ化学サービス
  • 毒性試験サービス
  • 細胞・遺伝子治療関連サービス
  • 前臨床・治験関連サービス
  • 創薬・薬剤開発の関連サービス
  • その他

第7章 臨床検査サービス市場：地域別の推定・動向分析

• 市場シェア分析：地域別（2023年・2030年）
• 市場ダッシュボード：地域別
• 世界市場のスナップショット：地域別
• 市場規模の予測と動向分析（2018～2030年）
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • コロンビア
  • ペルー
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 最近の動向と影響分析：主要市場参入企業別
• 企業/競合の分類
• ベンダー情勢
  • 主要な流通業者・チャネルパートナーの一覧
  • 主要顧客
  • 主要企業の市場シェア分析 (2023年)
  • LABORATORY CORPORATION OF AMERICA HOLDINGS（LABCORP）
  • QIAGEN
  • QUEST DIAGNOSTICS INCORPORATED
  • OPKO HEALTH, INC.
  • CHARLES RIVER LABORATORIES
  • ARUP LABORATORIES
  • SONIC HEALTHCARE
  • NEOGENOMICS LABORATORIES
  • FRESENIUS MEDICAL CARE.
  • SIEMENS HEALTHINEERS AG
  • SYNLAB INTERNATIONAL
  • MAYO CLINIC LABORATORIES
  • UNILABS
  • EUROFINS SCIENTIFIC

List of Tables

• Table 1 List of abbreviation
• Table 2 North America clinical laboratory services market, by region, 2018 - 2030 (USD Million)
• Table 3 North America clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 4 North America clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 5 North America clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 6 U.S. clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 7 U.S. clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 8 U.S. clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 9 Canada clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 10 Canada clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 11 Canada clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 12 Mexico clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 13 Mexico clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 14 Mexico clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 15 Europe clinical laboratory services market, by region, 2018 - 2030 (USD Million)
• Table 16 Europe clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 17 Europe clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 18 Europe clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 19 Germany clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 20 Germany clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 21 Germany clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 22 UK clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 23 UK clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 24 UK clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 25 France clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 26 France clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 27 France clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 28 Italy clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 29 Italy clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 30 Italy clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 31 Spain clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 32 Spain clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 33 Spain clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 34 Denmark clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 35 Denmark clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 36 Denmark clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 37 Sweden clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 38 Sweden clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 39 Sweden clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 40 Norway clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 41 Norway clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 42 Norway clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific clinical laboratory services market, by region, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 45 Asia Pacific clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 47 China clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 48 China clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 49 China clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 50 Japan clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 51 Japan clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 52 Japan clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 53 India clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 54 India clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 55 India clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 56 South Korea clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 57 South Korea clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 58 South Korea clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 59 Australia clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 60 Australia clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 61 Australia clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 62 Thailand clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 63 Thailand clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 64 Thailand clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 65 Latin America clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 66 Latin America clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 67 Latin America clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 68 Brazil clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 69 Brazil clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 70 Brazil clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 71 Argentina clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 72 Argentina clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 73 Argentina clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 74 Colombia clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 75 Colombia clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 76 Colombia clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 77 Peru clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 78 Peru clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 79 Peru clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 80 MEA clinical laboratory services market, by region, 2018 - 2030 (USD Million)
• Table 81 MEA clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 82 MEA clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 83 MEA clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 84 South Africa clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 85 South Africa clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 86 South Africa clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 89 Saudi Arabia clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 90 UAE clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 91 UAE clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 92 UAE clinical laboratory services market, by application, 2018 - 2030 (USD Million)
• Table 93 Kuwait clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
• Table 94 Kuwait clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
• Table 95 Kuwait clinical laboratory services market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Clinical laboratory services market: market outlook
• Fig. 14 Clinical laboratory services competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Clinical laboratory services market driver impact
• Fig. 20 Clinical laboratory services market restraint impact
• Fig. 21 Clinical laboratory services market strategic initiatives analysis
• Fig. 22 Clinical laboratory services market: Test Type movement analysis
• Fig. 23 Clinical laboratory services market: Test Type outlook and key takeaways
• Fig. 24 Genetic Testing market estimates and forecast, 2018 - 2030
• Fig. 25 Clinical chemistry market estimates and forecast, 2018 - 2030
• Fig. 26 Routine chemistry testing market estimates and forecast, 2018 - 2030
• Fig. 27 Therapeutic drug monitoring testing market estimates and forecast, 2018 - 2030
• Fig. 28 Endocrinology chemistry testing market estimates and forecast, 2018 - 2030
• Fig. 29 Specialized chemistry testing market estimates and forecast, 2018 - 2030
• Fig. 30 Other clinical chemistry testing market estimates and forecast, 2018 - 2030
• Fig. 31 Medical microbiology testing market estimates and forecast, 2018 - 2030
• Fig. 32 Infectious disease testing market estimates and forecast, 2018 - 2030
• Fig. 33 Transplant diagnostic testing market estimates and forecast, 2018 - 2030
• Fig. 34 Other microbiology testing market estimates and forecast, 2018 - 2030
• Fig. 35 Hematology testing market estimates and forecast, 2018 - 2030
• Fig. 36 Immunology testing market estimates and forecast, 2018 - 2030
• Fig. 37 Cytology testing market estimates and forecast, 2018 - 2030
• Fig. 38 Drug of abuse testing market estimates and forecast, 2018 - 2030
• Fig. 39 Other esoteric tests market estimates and forecast, 2018 - 2030
• Fig. 40 Clinical laboratory services market: Service Provider movement Analysis
• Fig. 41 Clinical laboratory services market: Service Provider outlook and key takeaways
• Fig. 42 Hospital-based laboratories market estimates and forecasts, 2018 - 2030
• Fig. 43 Stand-alone laboratories market estimates and forecasts,2018 - 2030
• Fig. 44 Clinic-based laboratories market estimates and forecasts,2018 - 2030
• Fig. 45 Clinical laboratory services market: application movement analysis
• Fig. 46 Clinical laboratory services market: application outlook and key takeaways
• Fig. 47 Bioanalytical & lab chemistry services market estimates and forecasts, 2018 - 2030
• Fig. 48 Toxicology testing services market estimates and forecasts,2018 - 2030
• Fig. 49 Cell & gene therapy related services market estimates and forecasts, 2018 - 2030
• Fig. 50 Preclinical & clinical trial related services market estimates and forecasts,2018 - 2030
• Fig. 51 Drug discovery & development related services market estimates and forecasts, 2018 - 2030
• Fig. 52 Other clinical laboratory services market estimates and forecasts,2018 - 2030
• Fig. 53 Global clinical laboratory services market: Regional movement analysis
• Fig. 54 Global clinical laboratory services market: Regional outlook and key takeaways
• Fig. 55 Global clinical laboratory services market share and leading players
• Fig. 56 North America market share and leading players
• Fig. 57 Europe market share and leading players
• Fig. 58 Asia Pacific market share and leading players
• Fig. 59 Latin America market share and leading players
• Fig. 60 Middle East & Africa market share and leading players
• Fig. 61 North America: SWOT
• Fig. 62 Europe SWOT
• Fig. 63 Asia Pacific SWOT
• Fig. 64 Latin America SWOT
• Fig. 65 MEA SWOT
• Fig. 66 North America
• Fig. 67 North America market estimates and forecasts, 2018 - 2030
• Fig. 68 U.S.
• Fig. 69 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 70 Canada
• Fig. 71 Canada market estimates and forecasts, 2018 - 2030
• Fig. 72 Europe
• Fig. 73 Europe market estimates and forecasts, 2018 - 2030
• Fig. 74 UK
• Fig. 75 UK market estimates and forecasts, 2018 - 2030
• Fig. 76 Germany
• Fig. 77 Germany market estimates and forecasts, 2018 - 2030
• Fig. 78 France
• Fig. 79 France market estimates and forecasts, 2018 - 2030
• Fig. 80 Italy
• Fig. 81 Italy market estimates and forecasts, 2018 - 2030
• Fig. 82 Spain
• Fig. 83 Spain market estimates and forecasts, 2018 - 2030
• Fig. 84 Denmark
• Fig. 85 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 86 Sweden
• Fig. 87 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 88 Norway
• Fig. 89 Norway market estimates and forecasts, 2018 - 2030
• Fig. 90 Asia Pacific
• Fig. 91 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 92 China
• Fig. 93 China market estimates and forecasts, 2018 - 2030
• Fig. 94 Japan
• Fig. 95 Japan market estimates and forecasts, 2018 - 2030
• Fig. 96 India
• Fig. 97 India market estimates and forecasts, 2018 - 2030
• Fig. 98 Thailand
• Fig. 99 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 100 South Korea
• Fig. 101 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 102 Australia
• Fig. 103 Australia market estimates and forecasts, 2018 - 2030
• Fig. 104 Latin America
• Fig. 105 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 106 Brazil
• Fig. 107 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 108 Mexico
• Fig. 109 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 110 Colombia
• Fig. 111 Colombia market estimates and forecasts, 2018 - 2030
• Fig. 112 Peru
• Fig. 113 Peru market estimates and forecasts, 2018 - 2030
• Fig. 114 Argentina
• Fig. 115 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 116 Middle East and Africa
• Fig. 117 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 118 South Africa
• Fig. 119 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 120 Saudi Arabia
• Fig. 121 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 122 UAE
• Fig. 123 UAE market estimates and forecasts, 2018 - 2030
• Fig. 124 Kuwait
• Fig. 125 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 126 Market share of key market players- clinical laboratory services market

Clinical Laboratory Services Market Growth & Trends:

The global clinical laboratory services market size is expected to reach USD 286.77 billion by 2030, registering a CAGR of 3.82% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the industry can be attributed to the increasing prevalence of the geriatric population, which, in turn, is propelling the demand for early disease diagnosis. The growing prevalence of target diseases, such as diabetes and Cardiovascular Diseases (CVDs), is a high impact-rendering driver for industry growth over the forecast period. Cardiovascular disease is the leading cause of death globally. The presence of unmet medical needs pertaining to disease management and the subsequent increase in patient awareness in more regions are expected to boost the demand for clinical laboratory testing.

Improvements in laboratory testing technology through break through and incremental advances are high-impact-rendering drivers for industry growth. Market firms are engaged in introducing new Servicess to serve the unmet demand of patients. For instance, in May 2022, Hamilton County entered into a partnership with Ethos Laboratories for the launch of no-cost COVID-19 testing sites. In July 2022, Mayo Clinic laboratories launched monkeypox tests to increase availability and accessibility to a wider target population. Moreover, in January 2022, Quest Diagnostics launched COVID-19 rapid antigen tests available through QuestDirect in collaboration with eMed to provide access to testing for COVID-19 at home. The pandemic affected millions of people globally. According to the CDC and WHO, the standard for diagnosis of COVID-19 is RT-PCR for samples from the respiratory tract.

The adoption of PCR technology for the diagnosis of COVID-19 and the genetic sequencing of the virus for the development of a cure is driving the industry. Due to this pandemic, there is an increase in the approval of tests for the diagnosis of the novel coronavirus, with most of these tests approved under Emergency Use Authorization (EUA) by federal agencies. Furthermore, the industry operates through different sales channels-laboratories and hospitals. The presence of prominent players in various regions is expected to drive the industry. For instance, in February 2022,Labcorp entered into a comprehensive partnership with Ascension. Through this collaboration, Labcorp will handle Ascension's hospital-based labs situated in ten states for buying assets for its outreach laboratory business.

Clinical Laboratory Services Market Report Highlights:

• Based on test type, the clinical chemistry segment led the market with the largest revenue share of 56.60% in 2024.
• Based on service provider, the hospital-based laboratories segment accounted for the largest market share in 2024.
• Based on application, the bioanalytical & lab chemistry services segment accounted for the largest revenue share in 2024.
• North America dominated the clinical laboratory services market with the largest revenue share of 37.24% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Test Type
  • 1.2.2. Service Provider
  • 1.2.3. Application
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Test Type outlook
  • 2.2.2. Service Provider outlook
  • 2.2.3. Application outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Clinical Laboratory Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Technological advancements in the field of clinical testing
    • 3.2.1.2. Growing prevalence of target diseases coupled with rising demand for early disease diagnostic tests
    • 3.2.1.3. Introduction of novel solutions
    • 3.2.1.4. Outbreak of COIVD-19 pandemic
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Presence of stringent regulatory framework
• 3.3. Clinical Laboratory Services Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
• 3.4. Pricing Analysis

Chapter 4. Clinical Laboratory Services Market: Test Type Estimates & Trend Analysis

• 4.1. Test Type Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Clinical Laboratory Services Market by Test Type Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Genetic Testing
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Clinical Chemistry
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.2. Routine Chemistry Testing Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.3. Therapeutic Drug Monitoring Testing Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.4. Endocrinology Chemistry Testing Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.5. Specialized Chemistry Testing Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.6. Other Clinical Chemistry Testing Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Medical Microbiology Testing
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3.2. Infectious Disease Testing Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3.3. Transplant Diagnostic Testing Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3.4. Other Microbiology Testing Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Hematology Testing
  • 4.4.5. Immunology Testing
  • 4.4.6. Cytology Testing
  • 4.4.7. Drug of Abuse Testing
  • 4.4.8. Other Esoteric Tests
    • 4.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Clinical Laboratory Services Market: Service Provider Estimates & Trend Analysis

• 5.1. Service Provider Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Clinical Laboratory Services Market by Service Provider Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Hospital-Based Laboratories
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Stand-Alone Laboratories
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Clinic-Based Laboratories
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Clinical Laboratory Services Market: Application Estimates & Trend Analysis

• 6.1. Application Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Clinical Laboratory Services Market by Application Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Bioanalytical & Lab Chemistry Services
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 6.4.2. Toxicology Testing Services
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Cell & Gene Therapy Related Services
    • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Preclinical & Clinical Trial Related Services
    • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Drug Discovery & Development Related Services
    • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.6. Others
    • 6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Clinical Laboratory Services Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework/ reimbursement structure
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework/ reimbursement structure
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework/ reimbursement structure
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework/ reimbursement structure
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework/ reimbursement structure
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework/ reimbursement structure
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.3. Colombia
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework/ reimbursement structure
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. Colombia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.4. Peru
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework/ reimbursement structure
    • 7.8.4.3. Competitive scenario
    • 7.8.4.4. Peru market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory framework/ reimbursement structure
    • 7.9.1.3. Competitive scenario
    • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework/ reimbursement structure
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework/ reimbursement structure
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework/ reimbursement structure
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2023
  • 8.3.4. LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. QIAGEN
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. QUEST DIAGNOSTICS INCORPORATED
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. OPKO HEALTH, INC.
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. CHARLES RIVER LABORATORIES
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. ARUP LABORATORIES
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. SONIC HEALTHCARE
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. NEOGENOMICS LABORATORIES
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. FRESENIUS MEDICAL CARE.
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. SIEMENS HEALTHINEERS AG
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. SYNLAB INTERNATIONAL
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives
  • 8.3.15. MAYO CLINIC LABORATORIES
    • 8.3.15.1. Company overview
    • 8.3.15.2. Financial performance
    • 8.3.15.3. Product benchmarking
    • 8.3.15.4. Strategic initiatives
  • 8.3.16. UNILABS
    • 8.3.16.1. Company overview
    • 8.3.16.2. Financial performance
    • 8.3.16.3. Product benchmarking
    • 8.3.16.4. Strategic initiatives
  • 8.3.17. EUROFINS SCIENTIFIC
    • 8.3.17.1. Company overview
    • 8.3.17.2. Financial performance
    • 8.3.17.3. Product benchmarking
    • 8.3.17.4. Strategic initiatives